Antimicrobial activity of ceftazidime-avibactam tested against Pseudomonas aeruginosa from China (2009-2010)

被引：0
|
作者：
Flamm, R. K. [1 ]
Jones, R. N. [1 ]
Sader, H. S. [1 ]
Wang, Y. [2 ]
Xu, Y. [2 ]
机构：
[1] JMI Labs, North Liberty, IA USA
[2] Peking Union Hosp, Beijing, Peoples R China
来源：
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS | 2013年 / 42卷
关键词：
D O I：
暂无
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
引用
收藏
页码：S62 / S62
页数：1
相关论文
共 50 条
  • [31] Ceftazidime-Avibactam in Combination With Fosfomycin: A Novel Therapeutic Strategy Against Multidrug-Resistant Pseudomonas aeruginosa
    Papp-Wallace, Krisztina M.
    Zeiser, Elise T.
    Becka, Scott A.
    Park, Steven
    Wilson, Brigid M.
    Winkler, Marisa L.
    D'Souza, Roshan
    Singh, Indresh
    Sutton, Granger
    Fouts, Derrick E.
    Chen, Liang
    Kreiswirth, Barry N.
    Ellis-Grosse, Evelyn J.
    Drusano, George L.
    Perlin, David S.
    Bonomo, Robert A.
    JOURNAL OF INFECTIOUS DISEASES, 2019, 220 (04): : 666 - 676
  • [32] A Selective Culture Medium for Screening Ceftazidime-Avibactam Resistance in Enterobacterales and Pseudomonas aeruginosa
    Sadek, Mustafa
    Poirel, Laurent
    Tinguely, Camille
    Nordmann, Patrice
    JOURNAL OF CLINICAL MICROBIOLOGY, 2020, 58 (09)
  • [33] CEFTAZIDIME/AVIBACTAM ACTIVITY AGAINST PSEUDOMONAS AERUGINOSA FROM ICU AND NON-ICU PATIENTS
    Sader, Helio
    Mendes, Rodrigo
    Castanheira, Mariana
    Flamm, Robert
    CRITICAL CARE MEDICINE, 2016, 44 (12)
  • [34] Longitudinal analysis of the in vitro activity of ceftazidime-avibactam vs. Pseudomonas aeruginosa, 2012-2016
    Stone, Gregory G.
    Smayevsky, Jorgelina
    Kazmierczak, Krystyna
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2020, 96 (01)
  • [35] Comparison of antimicrobial activity between ceftolozane-tazobactam and ceftazidime-avibactam against multidrug-resistant isolates of Escherichia coli, Klebsiella pneumoniae, and Pseudomonas aeruginosa
    Alatoom, Adnan
    Elsayed, Hashim
    Lawlor, Karen
    AbdelWareth, Laila
    El-Lababidi, Rania
    Cardona, Lysettee
    Mooty, Mohammad
    Bonilla, Maria-Fernanda
    Nusair, Ahmad
    Mirza, Imran
    INTERNATIONAL JOURNAL OF INFECTIOUS DISEASES, 2017, 62 : 39 - 43
  • [36] In vitro activity of ceftazidime-avibactam and comparators against Enterobacterales and Pseudomonas aeruginosa isolates from Central Europe and Israel, 2014-2017 and 2018
    Kristof, Katalin
    Adamkova, Vaclava
    Adler, Amos
    Gospodarek-Komkowska, Eugenia
    Rafila, Alexandru
    Billova, Sabina
    Mozejko-Pastewka, Barbara
    Kiss, Ferenc
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2021, 101 (01)
  • [37] In Vitro Activity of Cefepime-Zidebactam, Ceftazidime-Avibactam, and Other Comparators against Clinical Isolates of Enterobacterales, Pseudomonas aeruginosa, and Acinetobacter baumannii: Results from China Antimicrobial Surveillance Network (CHINET) in 2018
    Yang, Yang
    Guo, Yan
    Yin, Dandan
    Zheng, Yonggui
    Wu, Shi
    Zhu, Demei
    Hu, Fupin
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2021, 65 (01)
  • [38] In vitro activity of ceftazidime/avibactam against ceftazidime-resistant Enterobacterales and Pseudomonas aeruginosa from hospitalised patients in Germany
    Kresken, Michael
    Korte-Berwanger, Miriam
    Pfennigwerth, Niels
    Gatermann, Soren G.
    JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE, 2021, 25 : 337 - 338
  • [39] Ceftazidime-avibactam activity when tested against ceftazidime-nonsusceptible Citrobacter spp., Enterobacter spp., Serratia marcescens, and Pseudomonas aeruginosa from Unites States medical centers (2011-2014)
    Sader, Helio S.
    Castanheira, Mariana
    Farrell, David J.
    Flamm, Robert K.
    Jones, Ronald N.
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2015, 83 (04) : 389 - 394
  • [40] Ceftazidime-avibactam activity tested against Gram-negative bacterial pathogens in the Asia-Pacific regionand South Africa (2010)
    Flamm, R. K.
    Sader, H. S.
    Jones, R. N.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 : S63 - S63
12345